United Kingdom· GB-APID-44001711000001102
Amikacin 25mg/5ml solution for injection ampoules
A amikacin product containing amikacin, registered in United Kingdom by Special Order. The same ATC class is registered in 15 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Amikacin is registered in 15 of 19 countries.
Countries holding a registration under ATC J01GB06 (amikacin), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Amikacin · ATC J01GB06
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Amikacin
- Manufacturer
- Special Order
- Country
- United Kingdom (GB)
- ATC code
- J01GB06
- ATC class
- Amikacin
- Defined daily dose
- 0.59 g, Inhal
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
253 interactions on record for amikacin.
Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Amikacin · interactions on record
253 records
- 50 severe
- 133 moderate
- 2 minor
- 68 info
Most severe, free to view
- Magnesium sulfateA06AD04severe
- MannitolA06AD16severe
- Polymyxin BA07AA05severe
- Magnesium sulfateA12CC02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Amikacin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAMIKACIN B. BRAUNB. Braun Melsungen AG, Melsungen
- United Statesamikacin sulfateSagent Pharmaceuticals
- BelgiumAmikacine B. Braun 10 mg/mlB. Braun Melsungen
- PolandAmikacin AdamedAdamed Pharma S.A.
- ItalyAMIKACINA TEVATEVA ITALIA S.R.L.
- SpainAMICACINA B BRAUN 10 mg/ml SOLUCION PARA PERFUSION INTRAVENOSAB Braun Medical S.A.
- FinlandAmikacin Afortas2Care4 Generics ApS
- FranceAMIKACINE PANPHARMA 250 mg/mL, solution injectablePANMEDICA
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Amikacin B. Braun
- Belgium · Amikacine B. Braun, Amikacine Fresenius Kabi
- Bulgaria · Amikacin Kabi, Амикацин Б. Браун
- Cyprus · Amika-Synto, Amikacin Vioser
- Czechia · Amikacin B. Braun, Amikacin Fresenius Kabi
- Germany · Amikacin B. Braun, Amikacin Eberth
- Denmark · Amikacin Afortas, Amikacin Macure
- Estonia · Amikacin B. Braun
- Spain · Amicacina, Amicacina B. Braun
- Finland · Amikacin Afortas, Amikacin Macure
- France · Amikacine B. Braun, Amikacine Kabi
- Greece · Amicasil, Amikacin Anfarm
- Croatia · Amikacin Zentiva
- Hungary · Amikacin Anfarm, Amikacin B. Braun
- Ireland · Amikacin, Amikacin Athlone Pharmaceuticals
- Iceland · Arikayce Liposomal
- Italy · Amicasil, Amikacina B. Braun
- Liechtenstein · Arikayce Liposomal
- Lithuania · Biodacyna
- Luxembourg · Amikacin B. Braun, Amukin
- Latvia · Amikacin B.Braun
- Malta · Amikacin Tillomed Laboratories, Uzix
- Netherlands · Amikacine Hospira
- Norway · Amikacin Afortas, Amikacin Macure
- Poland · Amikacin B. Braun, Amikacin Kabi,
- Portugal · Amicacina Hikma, Amicacina Kabi
- Romania · Amikacin Noridem, Amikacină Atb
- Sweden · Amikacin Afortas, Amikacin Fresenius Kabi
- Slovenia · Amikacin Kabi
- Slovakia · Amikacin B. Braun, Amikacin Fresenius Kabi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/288e08c1-e2a1-49bd-917c-cbbd0a7cbcf3 GET /v1/drugs/288e08c1-e2a1-49bd-917c-cbbd0a7cbcf3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "44001711000001102",
"desc": "Amikacin 25mg/5ml solution for injection ampoules (Special Order)",
"form": "Solution for injection",
"vpid": "44007311000001107",
"source": "dmd",
"vtm_id": "774534000",
"strength": "5 mg",
"substance": "Amikacin",
"ingredient": "Amikacin sulfate",
"supplier_code": "8286711000001104"
}See everything about amikacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.